Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06620939
NA

The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence

Sponsor: Zhang Jian

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to determine whether the LNG-IUS is more effective to that of expectant in preventing endometrial polyp recurrence after hysteroscopic polypectomy. Researchers will compare LNG-IUS to expectant management to see if LNG-IUS works to reduce the recurrence rate of endometrial polyps. Participants will: Receive Mirena placement or not after hysteroscopic polypectomy; Be scheduled for a follow-up with TVCD to screen for endometrial polyps recurrence every 6 months.

Official title: The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence After Hysteroscopic Polypectomy: Protocol of a Multi-center Randomised Controlled Trial

Key Details

Gender

FEMALE

Age Range

20 Years - 48 Years

Study Type

INTERVENTIONAL

Enrollment

558

Start Date

2024-12-01

Completion Date

2028-12-31

Last Updated

2024-10-04

Healthy Volunteers

No

Interventions

DRUG

Levonorgestrel Intrauterine System (LNG-IUS)

Participants in the intervention group will receive Mirena placement after hysteroscopic polypectomy